Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Security class unavailable · CUSIP: 140755109

Event date: 2019-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,865,806
Percent of class
10.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-19-003014
Form type
SC 13G/A
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
Dec 10, 2019
Reporting period
Nov 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub